Radiation therapy firm Accuray said it has upsized its previously announced offering to $100 million in 3.75% convertible senior notes due 2016.
The offering size was increased from $75 million, and the notes were offered and sold to qualified institutional buyers, Accuray said. The sale is expected to close August 1.
